Doldi, V.; Lecchi, M.; Ljevar, S.; Colecchia, M.; Campi, E.; Centonze, G.; Marenghi, C.; Rancati, T.; Miceli, R.; Verderio, P.;
et al. Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate Cancer. Int. J. Mol. Sci. 2022, 23, 7987.
https://doi.org/10.3390/ijms23147987
AMA Style
Doldi V, Lecchi M, Ljevar S, Colecchia M, Campi E, Centonze G, Marenghi C, Rancati T, Miceli R, Verderio P,
et al. Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate Cancer. International Journal of Molecular Sciences. 2022; 23(14):7987.
https://doi.org/10.3390/ijms23147987
Chicago/Turabian Style
Doldi, Valentina, Mara Lecchi, Silva Ljevar, Maurizio Colecchia, Elisa Campi, Giovanni Centonze, Cristina Marenghi, Tiziana Rancati, Rosalba Miceli, Paolo Verderio,
and et al. 2022. "Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate Cancer" International Journal of Molecular Sciences 23, no. 14: 7987.
https://doi.org/10.3390/ijms23147987
APA Style
Doldi, V., Lecchi, M., Ljevar, S., Colecchia, M., Campi, E., Centonze, G., Marenghi, C., Rancati, T., Miceli, R., Verderio, P., Valdagni, R., Gandellini, P., & Zaffaroni, N.
(2022). Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate Cancer. International Journal of Molecular Sciences, 23(14), 7987.
https://doi.org/10.3390/ijms23147987
